607 results on '"Pasquier, David"'
Search Results
2. Reirradiation − still navigating uncharted waters?
3. Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France
4. Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database
5. Electrodialysis as a key operating unit in chemical processes: From lab to pilot scale of latest breakthroughs
6. Electrochemical degradation of diclofenac generates unexpected thyroidogenic transformation products: Implications for environmental risk assessment
7. Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
8. Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history
9. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
10. How the Xenopus eleutheroembryonic thyroid assay compares to the amphibian metamorphosis assay for detecting thyroid active chemicals
11. Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
12. Deep Learning Based Radiomics to Predict Treatment Response Using Multi-datasets
13. Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center
14. Achievable Dosimetric Constraints in Stereotactic Reirradiation for Recurrent Prostate Cancer
15. A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial
16. Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
17. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
18. Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study
19. Electrochemical degradation of 17α-ethinylestradiol: Transformation products, degradation pathways and in vivo assessment of estrogenic activity
20. Evaluation of surface image guidance and Deep inspiration Breath Hold technique for breast treatments with Halcyon
21. Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohort
22. Deep Learning Based Radiomics to Predict Treatment Response Using Multi-datasets
23. Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort
24. Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
25. Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group
26. Nodal radiotherapy for prostate adenocarcinoma recurrence: predictive factors for efficacy.
27. Radiomic feature robustness in CT scans affected by fiducial marker induced streak artifacts for patients with hepatocellular carcinoma.
28. Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort
29. ALADDIN: Evaluation of darolutamide addition to androgen deprivation therapy and radiation therapy in newly diagnosed prostate cancer with pelvic lymph nodes metastases.
30. Spray drift in field crops: A dataset to analyse the influence of air induction nozzles, hedges, and their combination on the reduction of sedimentary drift, aerial drift and exposure of bystanders
31. Direct and TEMPO‐Mediated Electro‐Oxidation of 5‐(Hydroxymethyl)furfural in Organic and Hydro‐Organic Media
32. An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation
33. OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
34. Fast computing flow battery modeling to optimize the choice of electrolytes and operating conditions – application to aqueous organic electrolytes
35. Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder
36. Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
37. The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review
38. Preclinical Study of Radiation on Fat Flap Regeneration under Tissue-engineering Chamber: Potential Consequences for Breast Reconstruction
39. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
40. Metformin: (future) best friend of the radiation oncologist?
41. Facteurs dosimétriques liés aux complications pulmonaires postopératoires dans les cancers de l’œsophage localement avancés traités par radiochimiothérapie préopératoire : revue de la littérature
42. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis
43. Radiotherapy in the treatment of extracranial hemangiopericytoma/solitary fibrous tumor: Study from the Rare Cancer Network
44. Stereotactic body radiotherapy as a viable treatment on extracranial oligometastases in melanoma patients: a retrospective multicentric study
45. Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07)
46. Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07)
47. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort
48. Stereotactic body radiotherapy for intramedullary metastases: a retrospective series at the Oscar Lambret center and a systematic review
49. Correlation between toxicity and dosimetric parameters for adjuvant intensity modulated radiation therapy of breast cancer: a prospective study
50. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.